Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.

Saved in:
Bibliographic Details
Title: Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy.
Authors: Benhima N; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet - Hôpital Erasme, Brussels, Belgium., Audisio A; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet - Hôpital Erasme, Brussels, Belgium; Azienda Ospedaliera S.Croce e Carle, Cuneo, Italy., Gallio C; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet - Hôpital Erasme, Brussels, Belgium; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Ricco G; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet - Hôpital Erasme, Brussels, Belgium; Policlinico S.Orsola-Malpighi, Bologna, Italy., Meillat H; Institut Paoli-Calmettes, Marseille, France., Velenik V; Institute of Oncology Ljubljana, Ljubljana, Slovenia., Riesco MC; Hospital Universitario 12 de Octubre, Madrid, Spain., Suárez Alecha J; Hospital Universitario de Navarra, Pamplona, Spain., Rasschaert G; University Hospitals Leuven - Campus Gasthuisberg, Leuven, Belgium., Páez López-Bravo D; Hospital de la Santa Creu i Sant Pau, IR SANT PAU, Barcelona, Spain., Tougeron D; CHU de Poitiers, Poitiers, France., Carvalho C; Champalimaud Clinical Centre, Lisbon, Portugal., Borelli B; Azienda Ospedaliera Universitaria Pisana, Pisa, Italy., Famiglietti F; CHU Charleroi, Charleroi, Belgium., De la Pinta C; Ramón y Cajal University Hospital, IRYCIS, Madrid, Spain., O'Connor JM; Instituto Alexander Fleming, Buenos Aires, Argentina., Artaç M; Necmettin Erbakan University, Faculty of Medicine, Konya, Turkey., Braam PM; Radboud University Medical Centre, Nijmegen, the Netherlands., Puccini A; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Medical Oncology and Hematology Unit, Humanitas Cancer Center, Rozzano, Milan, Italy., Waldhorn I; Rambam Health Care Campus, Haifa, Israel., Vanden Bulcke A; AZ Groeninge, Kortrijk, Belgium., Loi M; Azienda Ospedaliero Universitaria Careggi, Firenze, Italy., De Felice F; Policlinico Umberto I 'Sapienza' University of Rome, Rome, Italy., Eid M; University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Center for Precision Medicine, University Hospital Brno, Brno, Czech Republic., Deleporte A; CHU Saint-Pierre, University Hospital, Brussels, Belgium., Rossini C; ASST Ovest Milanese Presidi Legnano, Cuggiono, Milan, Italy., Montenegro P; Auna-Oncosalud, Lima, Peru., Fiore M; Università Campus Bio-Medico di Roma, &, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy., Van Den Eynde M; Institut Roi Albert II, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium., Shamseddine A; American University of Beirut Medical Center, Beirut, Lebanon., Geboes KP; Ghent University Hospital, Ghent, Belgium., Messina M; ARNAS Civico, Palermo, Italy., Mulet Margalef N; Institut Català d'Oncologia - Badalona and Germans Trias i Pujol Research Institute, Badalona, Spain., Houlzé-Laroye C; Claude Huriez Hospital, CHU Lille, Lille, France., Kirac I; IGET - Institute for Gastroenterological Tumours, and, University Hospital for Tumors, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia., Pastorino A; Ospedale Policlinico San Martino - IRCCS, Genoa, Italy., Salati M; University Hospital Modena, Modena, Italy., Argalácsová S; General University Hospital and, First Faculty of Medicine, Prague, Czech Republic., Morano F; Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano, Milan, Italy., Capdevila J; Vall d'Hebron University Hospital, Barcelona, Spain., Garajovà I; University Hospital of Parma, Parma, Italy., Antoun C; University Hospital of Besançon, Besançon, France., Sousa Pinto CM; Centro Hospitalar Universitário do Algarve-Hospital de Faro, Faro, Portugal., Lutz MP; Caritasklinikum St. Theresia, Saarbruecken, Germany., Adams RA; Cardiff University and, Velindre Cancer Centre, Cardiff, UK., Chau A; Polyclinique Hénin-Beaumont, Group Ahnac, Haut-de-France, France., Siebenhuener A; Klinik für Hämatologie und Onkologie, Hirslanden Zurich AG, Zurich, Switzerland., Dermine A; CHU Helora Hospital La Louvière Site Jolimont, La Louvière, Belgium., Ghidini M; Fondazione IRCCS, Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Dulskas A; Vilnius University Vilnius, Lithuania; National Cancer Institute, Vilnius, Lithuania., Papamichael D; Bank of Cyprus Oncology Centre, Nicosia, Cyprus., Javed MA; Liverpool University Hospitals Foundation Trust, Liverpool, UK., Ruiz-Garcia E; Instituto Nacional de Cancerología, Mexico City, Mexico., Tomášek J; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Petrillo A; Ospedale del Mare, Naples, Italy., Baratelli C; University of Turin, San Luigi Hospital Orbassano, Italy., Vandamme T; Antwerp University Hospital, Edegem, Belgium; Centre for Oncological Research (CORE), University of Antwerp, Faculty of Medicine & Health Sciences, Antwerp, Belgium., Spolverato G; University of Padova, Padova, Italy., Bock F; Rostock University Medical Center, Rostock, Germany., Diaz M; Centre Hospitalier Universitaire (CHU) Ambroise Paré, Mons, Belgium., Campana LG; Manchester University NHS Foundation Trust, Manchester, UK., Sur D; University of Medicine and Pharmacy Iuliu Haţieganu, Cluj-Napoca, Romania., Karampeazis A; 401 Army General Hospital, Athens, Greece., Patsko V; National Cancer Institute of Ukraine, Kyiv, Ukraine., Puleo F; Chirec Delta Hospital, Brussels, Belgium., Bounedjar A; University Blida 1 Laboratoire de cancérologie, Faculté de Médecin Blida Algeria, Algeria., Fiorica F; AULSS 9 Scaligera, Verona, Italy., Gilliaux Q; CHU UCL Namur, Site Godinne, Yvoir, Belgium., Bernardini I; Ospedale Ramazzini, Carpi, Modena, Italy., De Stefano A; Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italia., Grønlie Guren M; Oslo University Hospital, Oslo, Norway., Jakubauskas M; Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Sert F; Ege University Faculty of Medicine, Izmir, Turkey., Gomez Galdon M; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet - Hôpital Erasme, Brussels, Belgium., Veron Sanchez A; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet - Hôpital Erasme, Brussels, Belgium., Vierasu OI; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet - Hôpital Erasme, Brussels, Belgium., Assaf I; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet - Hôpital Erasme, Brussels, Belgium., Moretti L; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet - Hôpital Erasme, Brussels, Belgium., Martinive P; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet - Hôpital Erasme, Brussels, Belgium., Liberale G; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet - Hôpital Erasme, Brussels, Belgium., Van Laethem JL; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet - Hôpital Erasme, Brussels, Belgium., Sclafani F; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet - Hôpital Erasme, Brussels, Belgium. Electronic address: francesco.sclafani@hubruxelles.be.
Corporate Authors: International Real-World TNT Study Consortium
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jul 02; Vol. 245, pp. 116911. Date of Electronic Publication: 2026 Jul 02.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0852
DOI:10.1016/j.ejca.2026.116911